CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +1,093 | $1.57 | $2K | 36,766 |
| 2021-06-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +7,493 | $2.28 | $17K | 35,673 |
| 2021-01-26 | Harrell James Archie Jr Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2020-12-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +171 | $2.28 | $390 | 28,180 |
| 2020-06-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +6,391 | $2.28 | $15K | 28,009 |
| 2020-06-09 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +10,000 | $2.50 | $25K | 21,618 |
| 2020-04-09 | Harrell James Archie Jr Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +268,000 | 268,000 | ||
| 2019-12-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +3,064 | $2.85 | $9K | 11,618 |
| 2019-06-10 | Harrell James Archie Jr Exec. VP, Mktg & External Comm | Purchase | +4,398 | $2.85 | $13K | 8,554 |
Page 1 of 1 · 9 trades